Scientific and policy challenges to development of an AIDS vaccine

被引：33

作者：

Berkley, Seth Franklin ^{[1
]}

Koff, Wayne Chester ^{[1
]}

机构：

[1] Int AIDS Vaccine Initiat, New York, NY 10038 USA

来源：

LANCET | 2007年 / 370卷 / 9581期

关键词：

D O I：

10.1016/S0140-6736(07)61054-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：94 / 101

页数：8

共 65 条

[1] Fully Differentiated HIV-1 Specific CD8+T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection [J].

Addo, Marylyn M. ;

Draenert, Rika ;

Rathod, Almas ;

Verrill, Cori L. ;

Davis, Benjamin T. ;

Gandhi, Rajesh T. ;

Robbins, Gregory K. ;

Basgoz, Nesli O. ;

Stone, David R. ;

Cohen, Daniel E. ;

Johnston, Mary N. ;

Flynn, Theresa ;

Wurcel, Alysse G. ;

Rosenberg, Eric S. ;

Altfeld, Marcus ;

Walker, Bruce D. .

PLOS ONE, 2007, 2 (03)

[2] Potential public health impact of imperfect HIV type 1 Vaccines [J].

Anderson, R ;

Hanson, M .

JOURNAL OF INFECTIOUS DISEASES, 2005, 191 :S85-S96

[3] PATHOGENICITY OF LIVE, ATTENUATED SIV AFTER MUCOSAL INFECTION OF NEONATAL MACAQUES [J].

BABA, TW ;

JEONG, YS ;

PENNINCK, D ;

BRONSON, R ;

GREENE, MF ;

RUPRECHT, RM .

SCIENCE, 1995, 267 (5205) :1820-1825

[4] The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region [J].

Barnet, SW ;

Lu, S ;

Srivastava, I ;

Cherpelis, S ;

Gettie, A ;

Blanchard, J ;

Wang, S ;

Mboudjeka, I ;

Leung, L ;

Lian, Y ;

Fong, A ;

Buckner, C ;

Ly, A ;

Hilt, S ;

Ulmer, J ;

Wild, CT ;

Mascola, JR ;

Stamatatos, L .

JOURNAL OF VIROLOGY, 2001, 75 (12) :5526-5540

[5] HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells [J].

Betts, Michael R. ;

Nason, Martha C. ;

West, Sadie M. ;

De Rosa, Stephen C. ;

Migueles, Stephen A. ;

Abraham, Jonathan ;

Lederman, Michael M. ;

Benito, Jose M. ;

Goepfert, Paul A. ;

Connors, Mark ;

Roederer, Mario ;

Koup, Richard A. .

BLOOD, 2006, 107 (12) :4781-4789

[6] The global HIV/AIDS vaccine enterprise: Scientific strategic plan [J].

Bhan, MK ;

Berkley, S ;

DeWilde, M ;

Esparza, J ;

Fauci, AS ;

Gayle, H ;

Johnston, MI ;

Kaleebu, P ;

Kazatch-Kine, MD ;

Klausner, RD ;

Lander, ES ;

Makgoba, MW ;

Mocumbi, P ;

Piot, P ;

Quintana-Trias, O ;

Snow, W ;

Walport, MJ ;

Wigzell, H .

PLOS MEDICINE, 2005, 2 (02) :111-121

[7] Public health - A sound rationale needed for phase IIIHIV-1 vaccine trials [J].

Burton, DR ;

Desrosiers, RC ;

Doms, RW ;

Feinberg, MB ;

Gallo, RC ;

Hahn, B ;

Hoxie, JA ;

Hunter, E ;

Korber, B ;

Landay, A ;

Lederman, MM ;

Lieberman, J ;

McCune, JM ;

Moore, JP ;

Nathanson, N ;

Picker, L ;

Richman, D ;

Rinaldo, C ;

Stevenson, M ;

Watkins, DI ;

Wolinsky, SM ;

Zack, JA .

SCIENCE, 2004, 303 (5656) :316-316

[8] HIV vaccine design and the neutralizing antibody problem [J].

Burton, DR ;

Desrosiers, RC ;

Doms, RW ;

Koff, WC ;

Kwong, PD ;

Moore, JP ;

Nabel, GJ ;

Sodroski, J ;

Wilson, IA ;

Wyatt, RT .

NATURE IMMUNOLOGY, 2004, 5 (03) :233-236

[9] Dissection of the carbohydrate specificity of the broadly neutralizing-anti-HIV-1 antibody 2G12 [J].

Calarese, DA ;

Lee, HK ;

Huang, CY ;

Best, MD ;

Astronomo, RD ;

Stanfield, RL ;

Katinger, H ;

Burton, DR ;

Wong, CH ;

Wilson, IA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (38) :13372-13377

[10] Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41 [J].

Cardoso, RMF ;

Zwick, MB ;

Stanfield, RL ;

Kunert, R ;

Binley, JM ;

Katinger, H ;

Burton, DR ;

Wilson, IA .

IMMUNITY, 2005, 22 (02) :163-173

← 1 2 3 4 5 6 7 →